The Cooper Companies (COO)
(Delayed Data from NSDQ)
$92.61 USD
-0.20 (-0.22%)
Updated Dec 26, 2024 04:00 PM ET
After-Market: $92.77 +0.16 (0.17%) 6:52 PM ET
4-Sell of 5 4
C Value C Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
COO 92.61 -0.20(-0.22%)
Will COO be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for COO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COO
The Cooper Companies (COO) International Revenue in Focus: Trends and Expectations
Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls
COO: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Cooper Companies (COO) Reports Q4 Earnings: What Key Metrics Have to Say
The Cooper Companies (COO) Q4 Earnings Beat Estimates
Strong Segmental Sales to Drive Cooper Companies Q4 Earnings?
Other News for COO
First Week of August 2025 Options Trading For Cooper Companies (COO)
ICON appoints Barry Balfe as COO
Cooper Co Positioned for Growth: Buy Rating Backed by Market Leadership and Expansion
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them
Analysts Offer Insights on Healthcare Companies: Cooper Co (COO) and Merck & Company (MRK)